Eurofins Scientific SE

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: FR0014000MR3
EUR
57.68
0.22 (0.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Eurofins Scientific SE stock-summary
stock-summary
Eurofins Scientific SE
Miscellaneous
Eurofins Scientific SE is a Luxembourg-based company engaged in the business support services industry. The Company joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. It operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain. It is active through Ahma Group, Villapharma, Exova's environment testing laboratories in Eastern Canada, ASL analises ambientais in Brazil, MVZ fur Laboratoriumsmedizin am Hygiene-Institut Gmbh, Alphora Research, Genoma Laboratory Group, Ana Laboratories Inc, Lifecodexx AG, Gatc Biotech AG, Japan Analytical Chemistry Consultants Co. Ltd. (''Jacc''), Tsing Hua and Ecopro Research K.K. (''Ecopro'') and Craft Technologies.
Company Coordinates stock-summary
Company Details
23 val Fleuri , LUXEMBOURG None : 1526
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 4 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Gilles Martin
Chairman of the Board, Chief Executive Officer
Mrs. Valerie Hanote
Executive Director
Dr. Yves-Loic Martin
Executive Director
Mr. Stuart Anderson
Non-Executive Independent Director
Ms. Patrizia Luchetta
Non-Executive Independent Director
Mrs. Fereshteh Pouchantchi
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
243 Million
(Quarterly Results - Dec 2011)
Net Profit:
23 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

EUR 10,813 Million ()

stock-summary
P/E

200.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.07%

stock-summary
Debt Equity

1.21

stock-summary
Return on Equity

1.75%

stock-summary
Price to Book

3.15